From 1 January 1990 to 30 April 2018 ... PPI users were also more likely to have been prescribed NSAIDs, COX-2 inhibitors and SSRIs. Overall, most H2RA users entered the cohort earlier in the study ...

The researchers found that individual SGLT-2 inhibitors showed similar cardiovascular effectiveness at clinically effective ...

Nearly half of patients with advanced ovarian cancer treated with first-line poly-ADP-ribose polymerase (PARP) inhibitors experienced recurrence in this real-world study, emphasizing the need for ...

The new Prime Video series — which comes from producer Norman Lear, who died in December 2023 — premieres Feb. 6, and PEOPLE has an exclusive look at the trailer Laverne Cox is making her mark ...

With the RSK1 inhibitor already in clinical testing ... San Jose A, Liu J, Kim AB, Cox MJ, Fulbright MC, Jayanthan A, Los G, Rentschler SL, Ding L, Sakamoto KM, Dunn SE, Challen GA, Oh ST ...

reduced prostanoid synthesis and free radical generation without affecting the expression of COX-2 and mPGES-1 in neuronal cells. This effect may be attributed to the inhibition of COX activity ...

GLP-1 inhibitors such as semaglutide and tirzepatide have become popular and effective for weight loss and blood sugar control. However, they’re not without side effects. Keep in mind the following to ...

The aim of this report is to present the results of conversion therapy with Gemcitabine plus S-1 (GS) combined with PD-1 inhibitors (Zimberelimab) in a 74-year-old female IIIB iCCA patient. After 6 ...

No difference in thyroid cancer risk was found for adults with type 2 diabetes using a GLP-1 receptor agonist vs. those using a DPP-IV inhibitor. Women may have a lower risk for thyroid cancer ...

NSAIDs -- But Not COX-2s -- Inhibit Aspirin's Platelet Effects ASA Inhibits Thromboxane B2 Formation Who Gets the 'Chair' Opportunity for Counseling Patients NSAIDs -- But Not COX-2s -- Inhibit ...

Pfizer’s “golden egg” has hatched. The subcutaneous PD-1 inhibitor improved outcomes when added to the standard of care in bladder cancer, positioning the Big Pharma to file for approval of ...